Evaluation of a Correction Method for 111In-Pentetreotide SPECT Imaging of Gastroenteropancreatic Neuroendocrine Tumors.

The number of patients with the extremely rare disease gastroenteropancreatic (GEP) neuroendocrine tumor (NET) has increased rapidly in recent years. 111In-pentetreotide SPECT in somatostatin receptor scintigraphy has been used for the assessment of GEP NET patients. To diagnose GEP NET, appropriate...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Nuclear Medicine Technology Vol. 48; no. 3; pp. 1 - 31
Autores principales:	Takao Kanzaki, Yasuyuki Takahashi, Tetsuya Higuchi, Xieyi Zhang, Nao Mogi, Takayuki Suto, Yoshito Tsushima, Kanzaki, Takao, Takahashi, Yasuyuki, Higuchi, Tetsuya, Zhang, Xieyi, Mogi, Nao, Suto, Takayuki, Tsushima, Yoshito
Formato:	Journal Article
Publicado:	Society of Nuclear Medicine Sep2020
Acceso en línea:	Ver este registro en EBSCOhost